Symposia: Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, clinical trials, adult, Translational Research, assays, bioinformatics, genomics, Combination therapy, Clinical Research, Diseases, Therapies, emerging technologies, Biological Processes, Myeloid Malignancies, survivorship, Technology and Procedures, Study Population, Human, Minimal Residual Disease , machine learning, molecular testing, omics technologies
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, clinical trials, adult, Translational Research, assays, bioinformatics, genomics, Combination therapy, Clinical Research, Diseases, Therapies, emerging technologies, Biological Processes, Myeloid Malignancies, survivorship, Technology and Procedures, Study Population, Human, Minimal Residual Disease , machine learning, molecular testing, omics technologies
Saturday, December 10, 2022: 4:00 PM-5:30 PM
388-390
(Ernest N. Morial Convention Center)
Moderators:
Alexandra Gomez-Arteaga, MD, Weill Cornell Medicine/New York Presbyterian Hospital
and
Shyam Ajay Patel, MD, PhD, University of Massachusetts Chan Medical School
Disclosures:
Patel: Pfizer: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees; Bristol Myers Squibb: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees.
4:00 PM
4:15 PM
4:30 PM
4:45 PM
5:00 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH